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Reply to the Editor: 
We thank Drs. Boehm and Reichart for their interest in 
our recent study on the role of adenosine in University of 
Wisconsin (UW) preservation solution. 1 In these studies 
we reported that omission of adenosine from UW solution 
markedly reduced the functional recovery of isolated 
perfused rabbit hearts after 18 hours of hypothermic 
(4 ~ C) preservation. Functional recovery in hearts pre- 
served with UW solution without adenosine was similar to 
that in hearts preserved with St. Thomas' Hospital solu- 
tion. We concluded that adenosine plays a key role in the 
enhanced myocardial preservation observed with UW 
solution. 
We agree with Drs. Boehm and Reichart that the 
question remains as to whether inclusion of adenosine in 
St. Thomas' Hospital solution would have produced the 
same functional recovery as in UW solution. Addition of 
adenosine to St. Thomas' Hospital solution would have 
likely produced the same interstitial fluid profile as seen 
with UW solution and improved the preservation, but, 
because the two solutions are so different in composition, 
it is difficult to say whether the functional recovery would 
have been equivalent to that of UW solution. However, 
the purpose of this study was to determine whether 
adenosine was a necessary component of UW solution, 
not to compare the preservation capabilities of the two 
different solutions. The St. Thomas' Hospital solution 
group was included in this study merely for comparison 
purposes. 
The composition of UW solution is based on the 
complications associated with prolonged hypothermia and 
ischemia, but few studies have assessed which of these 
components play an integral role in preservation. 2 The 
results of this study indicate that adenosine is a key 
component of UW solution. In addition, Ko and col- 
leagues 3 recently reported that reversal of the sodium- 
potassium composition or omission of hydroxyethyl starch 
resulted in less preservation of diastolic function after 6 
hours preservation (1~ to 2 ~ C) of canine hearts. We agree 
that the effects of the high potassium concentration (in 
UW solution) on vascular/endothelial function must be 
studied further; however, in this study no evidence was 
found of more vascular dysfunction in hearts preserved 
with UW solution than in those preserved with St. Tho- 
mas' Hospital solution. Furthermore, in the study by 
Amrani and colleagues 4 cited by the respondents, the 
cold-storage temperature was much higher (20 ~ C) than 
that for which the UW solution was designed (4 ~ C). 
In conclusion, on the basis of experimental results, it 
appears that UW solution may be superior to St. Thomas' 
Hospital solution for prolonged myocardial preservation 
because of the inclusion of adenosine and hydroxyethyl 
starch and its intracellular-based ionic composition. How- 
ever, because clinical preservation times have remained in 
the 4 to 5 hour range for the past decade, it is evident hat 
much Work remains to be done in the area of myocardial 
preservation for heart transplantation. 
Robert D. Lasley, PhD 
Department of Surgery 
University of Wisconsin at Madison 
Madison, WI 53792 
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Invited letter concerning: Biochemical and cellular 
characterization of cardiac valve tissue after 
cryopreservation or antibiotic preservation 
(J THORAC CAROIOVASC SUING 1994;108:63-7) 
To the Editor." 
The vexing question of whether aortic valve allografts 
survive longer when their donor cell population isviable at 
implantation has been debated now for more than 20 
years. Truly conclusive vidence in favor Of maintaining 
cell viability during the preparation and storage of grafts is 
still lacking. Most follow-up studies of so-called "viable" 
valve grafts have not attempted to establish the persis- 
tence of donor cells in the explanted valves or to define 
the histologic status of the grafts. A notable exception is 
the paper of O'Brien and colleagues, 1 who demonstrated 
persistent donor cells in one single case of the series they 
studied. Despite good cellularity, however, this graft did 
not exhibit normal eaflet architecture. Without adequate 
cytologic and histologic information on the "viable" graft 
at the end of its useful life, the possibility remains 2 that 
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the presence of live cells at implantation simply indicates 
a better overall condition of the connective tissue, espe- 
cially the collagen. 
Very recently, we have shown that significant changes in 
the radial, elastic stretch properties of aortic valve leaflets 
occur both during life in the normal human population 3 
and in aortic allografts after implantation. 4 These biome- 
chanical changes are of such large magnitude that they 
must be an important cause of central incompetence and, 
ultimately, of allograft failure. We found that the mode of 
preparation of the allograft and its degree of cellularity at 
explantation had little bearing on the loss of leaflet stretch 
that occurred during implantation. However, the elastic 
stretch for aortic valve leaflets was strongly dependent on 
the donor age, which suggests that other properties of the 
leaflet tissue may also undergo significant change 'with 
age. 
Whatever inherent advantages "viable" valve grafts may 
possess in respect of their clinical durability, it is advisable 
to remember that the doctrine of "immunologic privi- 
lege," on which the viability theory was founded, has now 
been seriously challenged, and it can no longer be as- 
sumed that donor cells alive at implantation will necessar- 
ily survive and function indefinitely. Experimental studies 
have clearly shown that aortic valves are indeed antigenic 
and that the degree of antigenicity is related to the degree 
of histocompatibility between donor and recipient. 5'6 
Because it is not practicable to tissue-match valve grafts to 
their recipients, it is likely that donor cells persist after 
implantation only if there has been a fortuitously good 
tissue match. Noteworthy in this regard is the frequently 
overlooked investigation of Wheatley and McGregor. v
Using a dog model, these investigators showed that the 
cell population of known viable allograft valves explanted 
after 1, 4, or 8 weeks could be of either donor or recipient 
origin. It is also significant hat recipient cells have been 
detected in a clinical graft explanted at 10 months for 
prolapse of a leaflet, 2although the viability of this valve at 
implantation is not certain. Thus, when donor cells are 
detected in clinical explants, the degree of donor-recipient 
tissue match should also be determined. 
The long controversy regarding valve graft viability has 
been due in large part to the fact that preparation 
procedures vary from institution to institution, so that 
accurate comparisons are difficult or impossible t(y make. 
Confusion could be minimized if each group determined 
the preimplantation viability status of its own grafts as 
routinely prepared. The recent paper by Lang and asso- 
ciates 8 in this JOURNAL therefore represents a welcome 
move in this direction. Two specific aspects of their study 
raise particularly interesting considerations. 
First, the finding that 12 to 24 hours of treatment with 
an antibiotic solution containing an exceptionally high 
concentration of amphotericin B, together with an amin- 
oglycoside (gentamicin), does not alter viability, prolifer- 
ation, or metabolic status of the valves. Both the amino- 
glycosides and amphotericin are known to be markedly 
toxic to valve leaflet cells. 9 We TM have found that cell 
viability declines markedly or is completely lost after 24 
hours of exposure to an antibiotic solution without any 
aminoglycoside and with only one-twentieth t e concen- 
tration of amphotericin used by Lang's group. 1I There- 
fore, factors other than the composition of the sterilizing 
solution and the duration of exposure to it must be 
involved in determining the effects on cell viability. The 
interval between donor death and procurement of the 
valve (i.e., the period of autolysis) is a probable major 
influence, as hypoxically injured cells can be expected to 
be more susceptible to noxious substances than normal 
ones. The valves used by Lang and associates were all 
collected within 9 hours of donor death, whereas ours 
were collected for up to 30 hours after death. 
The second point of interest is the fact that all cells 
cultured were identified as endothelial cells, even in the 
control tissue samples. Inasmuch as the latter had only 
9 hours or less of postmortem autolysis, not only the 
dominant intracuspal cells of the valve leaflet (fibroblasts) 
but also the smooth muscle cells of the aortic wall could 
have been expected to remain viable in sufficient numbers 
to produce cultures, w' 12 It is difficult to speculate on the 
possible reasons for the failure of these cell types to grow 
when details of the culturing technique are not provided 
in the paper. It is perhaps significant hat the range of 
immunocytochemical probes used for the cell-type recog- 
nition did not include the commercially available antibody 
specific for cultured fibroblasts. 
The paper of Lang and associates 8 focuses our attention 
on the precise significance of viability relative to the 
function of the aortic all0graft. Key issues that still require 
clarification are as follows: 
1. tfow should "viability" be defined and assessed? Are 
persistent live cells that survive preparation and storage 
procedures and are capable of giving rise to cultures till 
necessarily fully functional? 
2. What is the actual value of "viable" cells in the 
preimplantation a d postimplantation contexts? Do these 
cells serve simply to indicate the overall quality of valve 
leaflet connective tissue before implantation? If they do 
survive implantation i  the long term, what interrelation- 
ships exist between cell function and the physical and 
mechanical conditions to which valve grafts are subjected? 
3. What is the likely relevance of these considerations 
to the overall biomechanical function of the allografts? 
Lois Armiger, PhD 
Grant Christie, PhD 
Brian Barratt-Boyes, MD 
Auckland, New Zealand 
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Further comments concerning: Biochemical and 
cellular characterization of cardiac valve tissue 
after cryopreservation or antibiotic preservation 
(J THORAC CARDmVASC SUR~ 1994;108:63-7) 
To the Editor: 
Because of my own recent work on valve viability, it has 
been of particular interest to me to be involved in 
commenting on the paper by Laflg and colleagues. I am 
indeed very pleased to see this type of study being 
undertaken and published. 
In our companion letter we raised two issues that seem 
particularly controversial. There are, however, several 
aspects of Dr. Lang's article that I find questionable or 
inadequate. I suspect that it could have been substantially 
improved by rather more rigorous reviewing, and I ven- 
ture to mention some examples of my points because of 
my concern that your JOURNAL should be publishing 
potentiNly important investigations in less than optimal 
form. 
First, with respect o the analytical parameters used, 
there is too little methodologic detail, which is not sup- 
plied by the references quoted. At least some of the 
omitted details may have had a bearing on the major 
findings. For example, could there have been a differential 
sensitivity of cell types to the enzymes used for tissue 
digestion, which resulted in the survival of only endothe- 
lial cells? (Enzyme concentrations, vehicle, and tempera- 
ture and duration of digestion should have been quoted.) 
Second, the reasons for the use of certain procedures 
are not made clear. For example, why were both frozen 
and paraffin sections used for histologic study if only 
hematoxylin and eosin staining was carried out? If immu- 
nohistochemistry for cell-type recognition in the intact 
tissue and/or histochemistry for specific components had 
been performed, the use of both would be understand- 
able. Furthermore, the reference given for structural 
examination (which is from my own group) used only 
paraffin sections but a whole battery of special stains, not 
just hematoxylin and eosin. 
Third, the significance of some of the observations i
not brought out adequately. For example, the persistence 
of the marker enzyme activities despite the loss of viability 
implies that only cell fragments are necessary for this 
"metabolic activity" (not at all surprising for membrane- 
associated enzymes). It should therefore be stressed that 
"metabolic status" determined in this way is not necessar- 
ily associated with the presence of intact, viable cells and 
should never be the sole method used to assess the status 
of valves. 
Fourth, the whole approach to cell-type recognition 
seems questionable when (a) fibroblasts are not even 
considered as a normal constituent of the tissues exam- 
ined (summary paragraph, point (1), pp. 66-67), (b) the 
reference quoted as the basis of the immunochemical 
methods used is a book on the endothelial cell only, and 
(c) the nature of the cells in the intact tissue was not 
determined, as touched on earlier. 
Lois C. Armiger, PhD 
Senior Research Fellow 
The University of Auckland 
Auckland, New Zealand 
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Liver function after cardiopuimonary bypass in 
children 
To the Editor: 
I read with interest the recently published article by 
Wang and colleagues 1 concerning hyperbilirubinemia af- 
ter cardiac surgical procedures, as I have performed a 
similar but more extensive study in a pediatric popula- 
tion. 2 
With theapproval of the local hospital Ethics Commit- 
tee and with informed parental consent, I investigated 36 
children, 30 of whom underwent cardiac operations in- 
volving the use of cardiopulmonary bypass and six oi 
whom underwent cardiac operations not involving the use 
